|
27 Mar 2007 |
JANUVIA(TM) Approved in the European Union for the Treatment of Type 2 Diabetes
|
|
27 Mar 2007 |
Momenta Pharmaceuticals Presents Preclinical Data for Novel Anticoagulant M118 At American College of Cardiology
|
|
27 Mar 2007 |
Clinical Data Completes Phase III Enrollment of Vilazodone for Depression
|
|
27 Mar 2007 |
HRA Pharma commences UK-based Phase III trial of Ella(R), a second-generation emergency contraceptive
|
|
27 Mar 2007 |
CombinatoRx, Incorporated (CRXX) Says Arthritis Drug Misses Primary Endpoint; Stock Falls
|
|
27 Mar 2007 |
Cephalon, Inc. (CEPH) Files Marketing Application for Approval of a Fentanyl Effervescent Buccal Tablet in Europe
|
|
26 Mar 2007 |
First Study To Show Positive Benefit On Atherosclerosis For People With Early Signs Of Diseased Arteries
|
|
26 Mar 2007 |
KAI Pharmaceuticals Presents Encouraging Phase 1/2 Results of a Novel Treatment for Heart Attack
|
|
25 Mar 2007 |
Schering-Plough's Novel Oral Thrombin Receptor Antagonist Meets Primary Endpoint in Phase II Trial
|
|
24 Mar 2007 |
Oral Cancer Drug REVLIMID(R) Receives Positive Opinion for Treatment of Multiple Myeloma From European Medicines Agency
|
|
24 Mar 2007 |
NovaDel's European Formulation of Ondansetron Targeted for U.S. Zensana(TM)
|
|
24 Mar 2007 |
Hana Biosciences Provides Pipeline Update
|
|
24 Mar 2007 |
Advancis Pharmaceutical Corporation (AVNC) Resubmits New Drug Application for Once-Daily Amoxicillin PULSYS
|
|
23 Mar 2007 |
Satraplatin Phase 3 SPARC Trial - Additional Data Presented at European Association of Urology Congress
|
|
23 Mar 2007 |
Xanthus Initiates a Phase 1 Study of Clomet for Treatment of Solid Tumors
|
|
23 Mar 2007 |
Cubist Pharmaceuticals Licenses Rights for Development and Commercialization of CUBICIN in Japan to Merck & Co., Inc.
|
|
23 Mar 2007 |
POZEN Announces Trexima(TM) (Sumatriptan Succinate and Naproxen Sodium) Amended Response Accepted for Review by FDA
|
|
23 Mar 2007 |
Aeolus Pharmaceuticals Announces Successful Completion of Multiple Dose Safety Study of AEOL 10150
|
|
22 Mar 2007 |
Evotec Initiates its First Phase I Clinical Study with EVT 302
|
|
22 Mar 2007 |
Amicus Therapeutics Presents Positive Results From Phase 1 Clinical Studies of Plicera(TM) for Gaucher Disease
|
|
22 Mar 2007 |
Encysive Pharmaceuticals Announces Patient Enrollment Initiated for TBC3711 Phase II Study
|
|
22 Mar 2007 |
Avicena Announces Patient Enrollment in National Institutes of Health (NIH) Phase III Parkinson's Disease Trial
|
|
22 Mar 2007 |
POZEN Announces Trexima(TM) (Sumatriptan Succinate and Naproxen Sodium) Amended Response Accepted for Review by FDA
|
|
21 Mar 2007 |
MGI PHARMA Announces Positive Results from a Pivotal Phase 3 Study of Aquavan(R) Injection in Patients Undergoing Bronchoscopy
|
|
21 Mar 2007 |
Abraxis BioScience to Initiate Two Phase I/II Clinical Trials with nab-docetaxel in Hormone Refractory Prostate and Metastatic Breast Cancer
|
